India's drug regulator CDSCO has found 53 drugs to be of non-standard quality in its latest test, which includes popular medicines like paracetamol, Vitamin D supplements, and antibiotics. These drugs are manufactured by various companies, including state-owned Hindustan Antibiotics. Some of these medicines were also linked to the deaths of 12 children in J&K in 2020, prompting tighter quality inspection measures in Gambia. In response to these findings, the CDSCO has revoked the power of state and UT authorities to grant no-objection-certificates for export purposes, and companies who received approvals in the past will have to report them to the central drug regulators. Stay updated with Fortune India on social media for more updates.
India Uncovers Substandard Drugs, Prompting Stringent Inspections
The Central Drugs Standard Control Organization (CDSCO), India's drug regulator, has exposed a startling trend in the country's pharmaceutical industry: 53 drugs of subpar quality. This discovery has sent shockwaves through the medical community and has led to heightened concerns about the safety of medications available to the public.
Background
India is a major player in the global pharmaceutical market, exporting drugs to over 200 countries. However, the revelation of substandard drugs raises questions about the quality control and regulatory oversight of the industry. In the past, India has been plagued by drug scandals involving fake and adulterated medicines.
The Latest Findings
The 53 subpar drugs include popular medicines such as paracetamol, Vitamin D supplements, and antibiotics. They were manufactured by various companies, including state-owned Hindustan Antibiotics. Some of the affected medicines were reportedly linked to the deaths of 12 children in Jammu and Kashmir in 2020.
Response from CDSCO
In light of these findings, the CDSCO has taken swift action:
Top 5 FAQs and Answers
1. What is the concern with the substandard drugs?
Answer: The drugs may not meet appropriate standards of purity, potency, or efficacy, potentially compromising patient safety.
2. Why were the drugs declared substandard?
Answer: The CDSCO conducted tests and found discrepancies in the composition, disintegration times, and other quality parameters.
3. What is being done to address the issue?
Answer: The CDSCO is conducting further investigations and revoking export approvals for affected companies. The government is also considering strengthening regulatory oversight of the pharmaceutical industry.
4. What should patients do if they have been taking the affected drugs?
Answer: Patients should consult with their healthcare providers to discuss alternative medications or further monitoring.
5. What measures are being taken to prevent future incidents?
Answer: The CDSCO is implementing stricter quality control procedures, increasing inspections, and considering enhanced penalties for manufacturers found in violation.
Conclusion
The discovery of substandard drugs in India highlights the importance of vigilant oversight and stringent regulation in the pharmaceutical industry. The CDSCO's swift response and the government's commitment to strengthen quality control measures demonstrate a determination to protect public health and ensure the safety of medications used by the nation's citizens.
The state government of Maharashtra has declared a day of mourning and proposed awarding the prestigious Bharat Ratna to late industrialist Ratan Tata. The country's top leaders and well-known personalities have paid their respects at NCPA where his mortal remains lie in state. The nation mourns the loss of this legendary businessman who made significant contributions to both industry and the social sector.
After Ratan Tata's 21-year tenure as chairman of Tata Sons, the conglomerate's market capitalization grew from Rs 30,000 crore to Rs 5 lakh crore, with revenues soaring from Rs 18,000 crore to Rs 5.5 lakh crore. Wholly committed to streamlining operations and enforcing a singular corporate identity across its various subsidiaries, Tata not only transformed the group into a globalized enterprise but also laid the groundwork for future success. His strategic decisions and well-timed acquisitions contributed significantly to the group's dramatic growth, earning him the title of Chairman Emeritus of Tata Sons.
The world mourns the passing of the legendary industrialist Ratan Tata, who not only left his mark in the business world but also tried his hand in Bollywood as a co-producer of the film Aetbaar. The film was a romantic psychological thriller starring Amitabh Bachchan, John Abraham, and Bipasha Basu. Despite his success in the business world, Ratan Tata's passing has not only left a void in the industry but also in Bollywood, with many celebrities sharing their heartfelt condolences and memories of his kindness and legacy.
As the world mourns the loss of legendary industrialist Ratan Tata, it is important to recognize his key contributions to the growth of Tata Group which led to the conglomerate achieving a market value of $365 billion. Through his bold decisions and global expansion drive, Tata Group acquired high-profile companies and achieved massive returns for shareholders and investors. His legacy continues to inspire and set an example for the business community.
In 2000, Tata Tea made headlines by acquiring global brand Tetley, twice its size. This groundbreaking purchase marked a defining moment for the Tata brand, leading to a string of other successful overseas acquisitions, including the luxury car brands Jaguar and Land Rover in 2008. The forward-thinking approach of Tata's leadership, led by Chairman Ratan Tata, propelled the company onto the global stage and cemented its position as a major player in the business world.
Ratan Tata, a man known for his integrity and philanthropy, passed away in Mumbai at the age of 86. Sudha Murty, Rajya Sabha MP and founder of Infosys Foundation, remembers him as a man of simplicity and compassion. With his passing, India has lost a true icon in the world of business and philanthropy.
Prime Minister Narendra Modi, along with other top leaders, have expressed their condolences and paid tribute to businessman-philanthropist Ratan Tata, who passed away on Wednesday evening. PM Modi remembered Tata for his extraordinary leadership and contributions to society, while Defence Minister Rajnath Singh called him a "Titan of Indian industry." Tata, who was awarded the Padma Vibhushan, is known for his monumental contributions to the economy, trade and industry.
The Minnesota Department of Transportation and the Department of Public Safety have begun a study to examine the shortage of commercial truck drivers in the state. With demand for drivers increasing due to online ordering, the industry is also facing a wave of retirements and a significant vacancy rate. The agencies are working with stakeholders to address challenges such as test access and driver compensation and plan to present their findings to the legislature in February. Stakeholders have raised concerns about wait times for CDL tests and the need for an extended appointment calendar.
Ratan Tata's death has left an irreplaceable void in the business world as well as in the hearts of millions across India, who admired him for his leadership, humility, and dedication to social causes. During his tenure as chairman of the Tata Group, he transformed the company into a global powerhouse with numerous iconic brands. Despite his immense wealth, Tata remained committed to giving back to society through the Tata Trust. His legacy will forever be remembered as a symbol of humility and philanthropy.
The business world mourns the loss of one of the greatest leaders and visionaries of modern times - Ratan Naval Tata. As Tata Sons announces his passing, his immense contribution in shaping the Tata Group and the nation is remembered. With unwavering commitment to excellence, integrity and innovation, Tata expanded the group’s global presence while remaining true to its moral compass. He will be remembered as a mentor, guide, and friend to many.